USPTO Deadlines
Next Deadline
24 days remaining
Non-Final Action E-Mailed
Due Date
January 22, 2026
Extension Available
Until April 22, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
46 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 22, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 22, 2025 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 22, 2025 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Oct 1, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 1, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Sep 16, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Oct 1, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Aug 14, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Sep 16, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Sep 16, 2025 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Sep 16, 2025 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Sep 16, 2025 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Sep 16, 2025 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Sep 15, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Sep 15, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 21, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 20, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 14, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 17, 2025 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Mar 17, 2025 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Mar 17, 2025 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Mar 17, 2025 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Mar 17, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Mar 17, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 10, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 10, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 15, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Dec 9, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 16, 2024 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Sep 16, 2024 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Sep 16, 2024 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Sep 16, 2024 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Sep 16, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Sep 16, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Feb 14, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 13, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 13, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 13, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 15, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 20, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 20, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 31, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 17, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 17, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 19, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 2, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
First Use Anywhere:
Feb 8, 2022
First Use in Commerce:
Feb 8, 2022
Classification
International Classes
005